Rankings
▼
Calendar
HRMY (Harmony Biosciences Holdings, Inc.) Stock Financials & Earnings | Market Cap Arena
HRMY
Harmony Biosciences Holdings, Inc.
Mkt Cap
$2B
Healthcare
·
Biotechnology
·
🇺🇸 United States
·
NASDAQ
Revenue (TTM)
$868M
Net Income (TTM)
$159M
EPS (TTM)
$2.71
Free Cash Flow (TTM)
$348M
Gross Margin
77.2%
Op. Margin
24.0%
Net Margin
18.3%
FCF Margin
40.1%
P/S Ratio (TTM)
1.9x
P/E Ratio (TTM)
10.4x
YoY Rev Growth
+21.5%
Employees
—
Earnings Reports
▶
Q4 2025
Browse All Reports
Quarterly
FY
Revenue & Profitability
Revenue
Gross Profit
Operating Income
Quarter
Revenue
Gross Profit
Op. Income
Q1 23
$119M
$98M
$40M
Q2 23
$134M
$109M
$47M
Q3 23
$160M
$128M
$65M
Q4 23
$168M
$125M
$40M
Q1 24
$155M
$127M
$52M
Q2 24
$173M
$141M
$21M
Q3 24
$186M
$143M
$62M
Q4 24
$201M
$147M
$56M
Q1 25
$185M
$153M
$56M
Q2 25
$200M
$162M
$48M
Q3 25
$239M
$180M
$65M
Q4 25
$244M
$175M
$39M
marketcaparena.com
Revenue Breakdown
HRMY
Harmony Biosciences Holdings, Inc.
Revenue Breakdown
Q4 2025
marketcaparena.com
Valuation
P/S Ratio
P/E Ratio
Quarter
P/S
P/E
Q1 23
3.5x
8.7x
Q2 23
3.3x
8.3x
Q3 23
3.1x
11.0x
Q4 23
2.8x
12.9x
Q1 24
2.7x
12.0x
Q2 24
2.5x
14.4x
Q3 24
2.4x
13.5x
Q4 24
2.3x
11.4x
Q1 25
2.2x
10.9x
Q2 25
2.1x
9.2x
Q3 25
2.0x
8.9x
Q4 25
1.9x
10.4x
marketcaparena.com
Operating Cash Flow
Operating Cash Flow
Free Cash Flow
Quarter
Operating CF
Free CF
Q1 23
$43M
$43M
Q2 23
$37M
$37M
Q3 23
$63M
$63M
Q4 23
$77M
$77M
Q1 24
$31M
$31M
Q2 24
$43M
$42M
Q3 24
$71M
$70M
Q4 24
$76M
$75M
Q1 25
$34M
$34M
Q2 25
$79M
$79M
Q3 25
$109M
$109M
Q4 25
$126M
$126M
marketcaparena.com
Capital Expenditures
CapEx
Quarter
CapEx
Q1 23
$0
Q2 23
$205K
Q3 23
$0
Q4 23
$107K
Q1 24
$5K
Q2 24
$632K
Q3 24
$3K
Q4 24
$513K
Q1 25
$128K
Q2 25
$4K
Q3 25
$71K
Q4 25
$107K
marketcaparena.com
OpEx vs Revenue Growth (YoY)
Revenue Growth
OpEx Growth
Quarter
Revenue Growth
OpEx Growth
Q1 23
+39.6%
+36.3%
Q2 23
+25.4%
+18.1%
Q3 23
+36.7%
-9.1%
Q4 23
+31.3%
+58.9%
Q1 24
+29.8%
+30.3%
Q2 24
+28.8%
+73.5%
Q3 24
+16.1%
+29.8%
Q4 24
+19.5%
+13.5%
Q1 25
+19.5%
+25.3%
Q2 25
+16.0%
+0.6%
Q3 25
+28.7%
+39.9%
Q4 25
+21.1%
+41.0%
marketcaparena.com
Stock-Based Compensation
SBC ($)
% of Revenue
Quarter
SBC ($)
% of Revenue
Q1 23
$7M
5.5%
Q2 23
$8M
5.8%
Q3 23
$8M
5.0%
Q4 23
$9M
5.3%
Q1 24
$10M
6.7%
Q2 24
$11M
6.3%
Q3 24
$11M
6.2%
Q4 24
$10M
5.0%
Q1 25
$12M
6.7%
Q2 25
$11M
5.7%
Q3 25
$11M
4.5%
Q4 25
$10M
4.2%
marketcaparena.com
OpEx Breakdown
R&D
G&A
S&M
Quarter
R&D
G&A
S&M
Q1 23
$13M
$22M
$23M
Q2 23
$15M
$23M
$25M
Q3 23
$17M
$23M
$23M
Q4 23
$30M
$28M
$27M
Q1 24
$22M
$26M
$27M
Q2 24
$64M
$27M
$29M
Q3 24
$25M
$29M
$28M
Q4 24
$35M
$29M
$28M
Q1 25
$35M
$31M
$31M
Q2 25
$50M
$34M
$30M
Q3 25
$55M
$30M
$30M
Q4 25
$50M
$58M
$29M
marketcaparena.com
War Chest
Cash & Equivalents
Short-Term Investments
Quarter
Cash
Short-term Investments
Total
Q1 23
$288M
$56M
$344M
Q2 23
$317M
$54M
$371M
Q3 23
$325M
$46M
$371M
Q4 23
$312M
$42M
$353M
Q1 24
$333M
$39M
$372M
Q2 24
$317M
$30M
$347M
Q3 24
$387M
$23M
$410M
Q4 24
$453M
$14M
$467M
Q1 25
$489M
$18M
$507M
Q2 25
$546M
$19M
$565M
Q3 25
$647M
$26M
$673M
Q4 25
$753M
$23M
$775M
marketcaparena.com
Shares Outstanding
Shares Outstanding
Quarter
Shares (Diluted)
QoQ Change
Q1 23
61M
-0.6%
Q2 23
61M
-0.8%
Q3 23
61M
-0.1%
Q4 23
59M
-3.0%
Q1 24
58M
-2.1%
Q2 24
58M
-0.1%
Q3 24
58M
+1.0%
Q4 24
58M
+0.2%
Q1 25
59M
+0.5%
Q2 25
58M
-0.2%
Q3 25
59M
+0.5%
Q4 25
59M
-0.0%
marketcaparena.com
Revenue Per Employee
Revenue / Employee
Year
Revenue/Employee
Employees
FY 18
—
—
FY 19
—
—
FY 20
$1M
150
FY 21
$2M
180
FY 22
$2M
200
FY 23
$2M
250
FY 24
$3M
268
FY 25
$43K
20K
marketcaparena.com